-
Rottlerin: Selective PKC Inhibitor for Advanced Cell Sign...
2026-01-21
Rottlerin stands out as a potent and selective PKCδ inhibitor, enabling researchers to unravel complex signaling pathways in cancer, virology, and endothelial biology. Its defined activity profile, robust in vitro and in vivo efficacy, and translational potential make it an indispensable tool for dissecting cell proliferation inhibition and apoptosis induction.
-
ABT-888 (Veliparib): Potent PARP1/2 Inhibitor for Cancer ...
2026-01-20
ABT-888 (Veliparib) is a highly selective poly (ADP-ribose) polymerase (PARP) inhibitor that sensitizes cancer models—especially those with microsatellite instability—to chemotherapy and radiation. Its robust DNA repair inhibition profile and in vivo efficacy make it a reference tool for research in DNA damage response pathways.